CPA
TEVA icon

Court Place Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Court Place Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-13,461
Closed -$211K – 185
2019
Q1 		$211K Sell
13,461
-140
-1% -$2.47K 0.09% 170
2018
Q4 		$210K Buy
+13,601
New +$279K 0.1% 156
2018
Q3 		– Sell
-9,034
Closed -$220K – 181
2018
Q2 		$220K Buy
+9,034
New +$184K 0.09% 160
2017
Q4 		– Sell
-14,455
Closed -$254K – 173
2017
Q3 		$254K Buy
14,455
+2,688
+23% +$60.5K 0.11% 145
2017
Q2 		$391K Buy
11,767
+2,435
+26% +$75.4K 0.19% 110
2017
Q1 		$299K Buy
9,332
+875
+10% +$29.9K 0.15% 121
2016
Q4 		$307K Buy
+8,457
New +$338K 0.16% 115

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Court Place Advisors's TEVA Position: Q2 2019 in Review

Court Place Advisors sold out of Teva Pharmaceuticals (TEVA) in Q2 2019, closing a stake of 13,461 shares — an estimated $211K sold.

Court Place Advisors first reported a position in TEVA in Q4 2016 and held it in 7 quarters. The position peaked at $391K in Q2 2017. 452 funds tracked by Wall St. Rank hold TEVA as of Q2 2019.

  • Court Place Advisors reported no remaining Teva Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Court Place Advisors sold 13,461 Teva Pharmaceuticals shares in Q2 2019, an estimated $211K.
  • Court Place Advisors first reported a position in Teva Pharmaceuticals in Q4 2016 and held it in 7 quarters.
  • Court Place Advisors's Teva Pharmaceuticals position peaked at $391K in Q2 2017.
  • 452 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2019.

Based on Court Place Advisors's 13F filing for Q2 2019, filed 30 Jul 2019.